Skip to main content
. 2019 Apr 4;1:100009. doi: 10.1016/j.vpoa.2019.100009

Table 3.

Fleas recovered in premises traps in homes when dogs were administered two monthly oral treatments of lotilaner or spinosad.

Study week n Geometric mean Percent change from Day 0 Arithmetic mean Percent change from Day 0 SD Minimum Median Maximum p-values*
Between group
0 Spinosad 22 22.2 0.0 46.4 0.0 107.8 5.0 23.0 524.0 0.642
Lotilaner 22 19.2 0.0 30.8 0.0 36.4 4.0 20.0 152.0
1 Spinosad 22 3.6 83.7 83.0 −78.8 366.2 0.0 2.0 1722.0 0.806
Lotilaner 22 4.1 78.5 7.2 76.5 8.4 0.0 4.0 26.0
2 Spinosad 19 3.8 82.8 64.4 −38.8 259.6 0.0 2.0 1136.0 0.895
Lotilaner 22 3.9 79.4 8.9 71.1 15.5 0.0 3.0 70.0
3 Spinosad 21 5.0 77.4 31.0 33.3 71.8 0.0 3.0 284.0 0.182
Lotilaner 21 2.7 85.7 4.6 85.1 4.4 0.0 4.0 13.0
4 Spinosad 20 1.7 92.5 10.2 78.1 33.0 0.0 0.5 148.0 0.815
Lotilaner 20 2.1 89.0 4.1 86.8 6.2 0.0 2.0 26.0
5 Spinosad 19 0.5 97.6 1.9 95.9 5.5 0.0 0.0 23.0 0.368
Lotilaner 18 0.5 97.5 1.1 96.6 2.5 0.0 0.0 10.0
6 Spinosad 19 0.3 98.5 0.8 98.3 2.0 0.0 0.0 7.0 0.316
Lotilaner 20 0.2 98.8 0.5 98.5 1.4 0.0 0.0 6.0
7 Spinosad 18 0.2 99.3 0.4 99.2 1.4 0.0 0.0 6.0 0.169
Lotilaner 20 0.1 99.7 0.1 99.7 0.5 0.0 0.0 2.0
8 Spinosad 18 0.1 99.7 0.1 99.8 0.5 0.0 0.0 2.0 0.257
Lotilaner 20 0.1 99.7 0.1 99.7 0.5 0.0 0.0 2.0

SD Standard deviation.

*

Within group p-values (based on geometric means) comparison to Day 0 generated by the Wilcoxon signed rank test. Week 1 through Week 8, for both groups p < 0.001. Between group p-values generated by repeated measures analysis of variance with Group, Week and Group by Week as fixed effects.